Knowledge, Attitudes, and Practices of Pharmacovigilance and ADRs Spontaneous Reporting Among Pediatricians and Pediatric Residents in Jordan.

IF 3.2 Q2 Pharmacology, Toxicology and Pharmaceutics

Current clinical pharmacology Pub Date : 2018-01-01 DOI:10.2174/1574884713666180308151805

Tareq L Mukattash, Maysaa W Alwadi, Rana K Abu-Farha, Anan S Jarab, Sameh A Al-Zubiedi, Tareq Alwedyan

{"title":"Knowledge, Attitudes, and Practices of Pharmacovigilance and ADRs Spontaneous Reporting Among Pediatricians and Pediatric Residents in Jordan.","authors":"Tareq L Mukattash, Maysaa W Alwadi, Rana K Abu-Farha, Anan S Jarab, Sameh A Al-Zubiedi, Tareq Alwedyan","doi":"10.2174/1574884713666180308151805","DOIUrl":null,"url":null,"abstract":"Introduction: Pharmacovigilance (PV) is the science responsible for ADRs reporting and accordingly medication safety. Pediatrics age group is a special concern as they have a higher risk of developing ADRs; this put more burden on pediatricians for early detection and reporting of ADRs. The present study aims to explore pediatricians' knowledge, attitude, and practices of pharmacovigilance.Method: A structured validated questionnaire was designed to achieve the study goals. A convenient sample of 142 pediatricians took part in the study.Results: The majority of pediatricians had a poor knowledge score about pharmacovigiliance and ADRs reporting. On the other hand, 71% of respondents had a good attitude score towards reporting ADRs. When exploring their own practice, pediatricians have a low reporting rate.Conclusion: The results of the present study reveal that pediatricians lack knowledge of PV and ADRs reporting. However, they have a good attitude towards ADRs reporting and enhancing their PV practice. This is still not reflected in their own practice. Further training and education about ADRs reporting are very important to move toward safer medications in children.","PeriodicalId":10746,"journal":{"name":"Current clinical pharmacology","volume":null,"pages":null},"PeriodicalIF":3.2000,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"9","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current clinical pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1574884713666180308151805","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}

引用次数: 9

Abstract

Introduction: Pharmacovigilance (PV) is the science responsible for ADRs reporting and accordingly medication safety. Pediatrics age group is a special concern as they have a higher risk of developing ADRs; this put more burden on pediatricians for early detection and reporting of ADRs. The present study aims to explore pediatricians' knowledge, attitude, and practices of pharmacovigilance.

Method: A structured validated questionnaire was designed to achieve the study goals. A convenient sample of 142 pediatricians took part in the study.

Results: The majority of pediatricians had a poor knowledge score about pharmacovigiliance and ADRs reporting. On the other hand, 71% of respondents had a good attitude score towards reporting ADRs. When exploring their own practice, pediatricians have a low reporting rate.

Conclusion: The results of the present study reveal that pediatricians lack knowledge of PV and ADRs reporting. However, they have a good attitude towards ADRs reporting and enhancing their PV practice. This is still not reflected in their own practice. Further training and education about ADRs reporting are very important to move toward safer medications in children.

查看原文本刊更多论文

约旦儿科医生和儿科住院医师药物警戒和adr自发报告的知识、态度和实践。

药物警戒(PV)是负责adr报告和相应用药安全的科学。儿科年龄组是一个特别关注的问题，因为他们发生不良反应的风险更高;这增加了儿科医生早期发现和报告不良反应的负担。本研究旨在探讨儿科医生的药物警戒知识、态度和实践。方法:为达到研究目的，设计了一份结构化的有效问卷。142名儿科医生参与了这项研究。结果:大多数儿科医生对药物警戒和不良反应报告的知识得分较低。另一方面，71%的受访者对报告adr有良好的态度得分。在探索自己的实践时，儿科医生的报告率很低。结论:本研究结果显示儿科医生缺乏PV和adr报告的知识。然而，他们对adr报告和加强PV实践持良好态度。这一点至今还没有体现在自己的实践中。关于不良反应报告的进一步培训和教育对于向儿童提供更安全的药物非常重要。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current clinical pharmacology PHARMACOLOGY & PHARMACY-

CiteScore

3.60

自引率

0.00%

发文量

期刊介绍： Current Clinical Pharmacology publishes frontier reviews on all the latest advances in clinical pharmacology. The journal"s aim is to publish the highest quality review articles in the field. Topics covered include: pharmacokinetics; therapeutic trials; adverse drug reactions; drug interactions; drug metabolism; pharmacoepidemiology; and drug development. The journal is essential reading for all researchers in clinical pharmacology.